Biological Safety Cabinet Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Biological Safety Cabinet Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The biological safety cabinet market is expected to register a CAGR of 8.2% during the forecast period (2022-2027).

The SARS-CoV-2 pandemic has led to an increase in regulatory recommendations for ensuring biosafety levels for individuals working in laboratories. For instance, as per the Centers for Disease Control and Prevention, clinical laboratories handle patient samples including urine practice standard precautions, blood (and blood constituents), and respiratory specimens. The rising issuance of laboratory biosafety guidelines from regulators, including the World Health Organization, is set to propel the demand for biological safety cabinets across various regions.

Biosafety cabinets are divided into three classes namely class I, class II and class III. Class I provides protection only for the user and surrounding environment but no product protection. Class II provides protection for the user, environment and sample. Class III or glove boxes which provides maximum protection, High-Efficiency Particulate Air (HEPA) filter-ventilated cabinet fitted with glove ports and decontamination capabilities for entry and exit of material.

According to the World Health Organization (WHO), globally in the year 2020,each year, non-communicable diseases claim 41 million lives: That’s about 70 per cent of all global deaths While non-communicable diseases tend to manifest in adulthood, many have their origins in behaviours adopted during childhood and adolescence. Risk factors for these diseases are often preventable: Appropriate health interventions before, during and after pregnancy, and through childhood and adolescence, can significantly reduce their prevalence. Thus, increasing risk of communicable diseases and increasing research and development activities in biotechnology and pharmaceutical companies are the key driving factors in biological safety cabinet market.

Key Market TrendsPharmaceutical and Biotechnology Segment is Expected to Hold a Major Market Share in the Biological Safety Cabinet Market

Microbiological quality of drugs or biologics is necessary for pharmaceutical and biotechnology industries for efficacy and patient safety because microbial contamination of drugs causes adverse effects on patient health in terms of morbidity and mortality and as well as long-term adverse effects. Pharma and biopharma companies require a strong Research & Development facility because of which they need advanced facilities and equipment. In September 2021, According to the Federal Research and Development, the government had funded USD 54,565 million to businesses for new scientific development. The pharmaceutical and biotechnology segment is also likely to register significant growth in the forecast period.

As per the centers for disease control and prevention data published in March 2022, A total of 7,860 Tuberculosis cases were reported in 2021, 687 more than in 2020 (7,173) and 1,040 fewer than in 2019 (8,900) in the United States. From 2020 to 2021, Tuberculosis incidence (cases per 100,000 population) rose 9.4%, from 2.16 to 2.37, but remained 12.6% lower than during 2019 (2.71). In 2021, 71% of Tuberculosis cases occurred among non–United States-born persons, the same proportion as in 2020 and 2019. Incidence (cases per 100,000 population) among UniteStates-bornrn persons increased from 0.71 in 2020 to 0.79 in 2021 and among non-United States.-born persons from 11.71 in 2020 to 12.16 in 2021. Thus, the increasing cases of Tuberculosis are driving the demand for biological safety cabinets.

The pharmaceutical and Biotechnology Segment holds a significant market share in the biological safety cabinet market and is anticipated to show a similar trend over the forecast period. Advance technology-based products, increasing research and development activities, and rising investments in the medical sector and life sciences are the key driving factors in the Pharmaceutical and Biotechnology Segment.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a major market share in the global biological safety cabinet market due to high research and development activities in the pharmaceutical and biotechnology industries and increased risk of pandemic and communicable diseases in this region. For instance, As per the Global Statistics report published in 2021 by the U.S. Department of Health & Human Services and supported by the Minority HIV/AIDS Fund, There were around 37.7 million people across the globe with HIV in 2020. Of these, 36 million were adults and 1.7 million were children aged 0-14 years. More than half (53%) were women and girls. Similarly, According to the World Malaria Report published in 2021 by the Centers for Disease Control and Prevention (CDC), malaria caused an estimated 241 million clinical episodes and 627,000 deaths globally. An estimated 95% of deaths in 2020 were in the World health organization (WHO) African Region. Additionally, According to the World Health Organization, around 71 million people have chronic hepatitis infections around the globe in 2020. While around 223 million people are living with viral hepatitis B and C 617,143 deaths per year are caused by hepatitis B virus infection 7 % of people live with hepatitis B and 19% live with hepatitis C. Moreover, According to the Centers for Disease Control and Prevention article published in 2020, Healthcare-associated infections (HAIs) are complications of healthcare and linked with high morbidity and mortality. Each year, about 1 in 25 U.S. hospital patients is diagnosed with at least one infection related to hospital care alone; additional infections occur in other healthcare settings. Many HAIs are caused by the most urgent and serious antibiotic-resistant (AR) bacteria and may lead to sepsis or death. However, Reports of sexually transmitted diseases dropped in the early months of the pandemic but saw a resurgence toward the end of 2020, according to new data from the Centers for Disease Control and Prevention (CDC). Furthermore, according to the CDC’s 2020 STD Surveillance Report, cases of gonorrhea and syphilis were up 10 percent and 7 percent, respectively, at the end of 2020 when compared to 2019. In addition to this, In 2021, As per the world health organization estimates, According to the data, 59,07,572 cases of acute diarrheal diseases were reported in 2021, 89,34,341 cases were recorded in 2020, and 1,76,47,630 such cases were reported in 2019 in India. Thus, rising incidences of chronic diseases and the quick adoption of advanced technologies, in the region further contribute to the regional market growth.

Competitive Landscape

The Biological Safety Cabinet Market is highly fragmented and competitive and consists of several major players. In terms of market share, few of the major players are currently dominating the market. Some of the major players have used various strategies such as expansions, agreements, joint ventures acquisitions, new product launches, partnerships and others to increase their footprints in this market. Some of the companies which are currently dominating the market are Thermo Fisher Scientific, Esco Micro, Labconco, The Baker Company, Kewaunee Scientific, NuAire, Germfree Laboratories, Cruma, Air Science and BIOBASE.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

Please note: This publisher does offer titles that are created upon receipt of order. If you are purchasing a PDF Email Delivery option above, the report will take approximately 2 business days to prepare and deliver.